News

The FTSE 100 index closed up 24.59 points, 0.3%, at 8,875.22, just shy of its record closing peak of 8,884.92 posted last ...
This trial evaluated the safety, tolerability, pharmacodynamics, pharmacokinetics and clinical activity of AstraZeneca’s ...
With this quintet of FTSE 100 stocks, an investor would have portfolio exposure stretching from the Americas and Europe to Africa and Asia. The post 5 top FTSE 100 stocks offering plenty of global ...
Radioligand Therapy Market is set to grow rapidly, rising from $2.41B in 2024 to $15.80B by 2033, driven by advanced cancer treatments and targeted therapies. The U.S. Radioligand Therapy Market is ...
Cancer researchers discovered how exercise really can be like a drug for colon cancer, and AstraZeneca's immunotherapy drug ...
Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season  Paris, June 9, 2025. Sanofi is shipping Beyfortus (nirsevimab) starting in early ...
The EC has granted approval for a fixed-duration regimen of AstraZeneca's Calquence (acalabrutinib) plus venetoclax.
When an RSV vaccine became available for use during pregnancy, it offered a natural experiment between various countries to ...
Causeway’s Sarah Ketterer likes AstraZeneca and Gucci’s parent company, Kering. Where else she’s picking up bargains.
In addition, mirvetuximab soravtansine (Elahere) was the first targeted therapy to demonstrate an improvement in OS in ...
Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, ...